about
TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoproteinO-GlcNAcylation regulates EZH2 protein stability and functionThe H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theoryPolycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic ImplicationsTargeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessTargeting CSC-related miRNAs for cancer therapy by natural agentsFocused examination of the intestinal epithelium reveals transcriptional signatures consistent with disturbances in enterocyte maturation and differentiation during the course of SIV infectionPrognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysisJNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenicOncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressorsPharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studiesCancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer.Molecular biology. EZH2 goes solo.EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesisMechanisms by which SMARCB1 loss drives rhabdoid tumor growth.Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancersQuantitative analysis of EZH2 expression and its correlations with lung cancer patients' clinical pathological characteristics.FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.EZH2: novel therapeutic target for human cancerEZH2, a unique marker of malignancy in effusion cytology.Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4.VprBP (DCAF1): a promiscuous substrate recognition subunit that incorporates into both RING-family CRL4 and HECT-family EDD/UBR5 E3 ubiquitin ligasesEzh2-mediated repression of a transcriptional pathway upstream of Mmp9 maintains integrity of the developing vasculature.The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expressionImmunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersAntitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.Structural insights into binding of small molecule inhibitors to Enhancer of Zeste Homolog 2.Histone methylases as novel drug targets: developing inhibitors of EZH2.Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growthEnhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysisHepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.Identification of differentially expressed genes associated with the enhancement of X-ray susceptibility by RITA in a hypopharyngeal squamous cell carcinoma cell line (FaDu).EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.Expression Profile and Function Analysis of LncRNAs during Priming Phase of Rat Liver Regeneration.Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.
P2860
Q24308021-128FB35D-2893-4B2F-A207-C76F5FCC3661Q24324113-172AB17A-0FCB-4CD7-A473-DF1F6BC04247Q26780223-64C9B5E4-059B-438D-A576-9378AAE01515Q26801380-6D22DC26-48A2-40A1-9299-69DACDFE6268Q26822776-8558D31A-BA69-4D03-A6BF-6735D991B6EBQ27003230-672EE293-65E3-4536-BA2A-4537DCF073EAQ27331953-D9CD84A4-F884-4E09-9DBD-10FB3A438AF9Q27853296-69019F12-D8F0-48D3-A94C-3FC894429A82Q28394303-E0252893-A27E-4206-A208-710934D45436Q28510632-1D01CD7F-6BA3-496C-AF40-57331EC946D7Q28535154-C175027F-9905-4131-8DA9-D2EC029563BEQ33667093-A0406007-4970-4F1F-AB9B-CD0366A03C41Q33705036-848A0766-4A5E-4EA8-8BF6-B7C646FED8A1Q34034771-30D0AE17-EC62-4F33-A687-244CD6537180Q34199631-C5D5CA2A-DE49-493C-B08F-B89835836339Q34332647-6B6C39F0-B5FA-40E5-826A-3D78ACAD58DFQ34357952-735562E4-2470-42DE-BE50-196056F506F2Q34362220-041AD408-38B5-4CDD-A412-623834CD8035Q34419383-E2878B23-C4AC-4EAE-A111-CB7AA97E4994Q34691625-F928A484-47F5-4578-867E-98D0FB544129Q34699488-F7DB730F-184E-4FA2-BA48-D59E36D10158Q34982573-B3A81BB9-D681-49EA-BBC7-24BAF2269DDEQ34986007-66FE140F-B974-4E3D-AFD8-FD08FC0D7D45Q34999341-CD2828BE-DB8B-45A7-B7E9-0722014649EDQ35025421-8630B0ED-2F3D-4B6C-A05D-6FC5D67691D8Q35151124-7AEEFAEF-8311-4B10-ADD5-DF3AB7E09CA2Q35170116-15442FA5-3FF5-4352-97CC-4C5536513706Q35228394-06DB2586-40C9-4413-8722-6E977F0373EEQ35510392-11D9A83C-B7F6-4E43-B25D-F9B2DDC68FD5Q35550139-D159BB4B-88FB-41A5-82E4-ED305A570331Q35606640-C3019A66-358D-49FE-8B00-89A39F6B2511Q35609669-7DB434C9-D8B4-4FC8-821A-6F4BED07ADD4Q35677250-4F4A5215-8F38-4AA5-8EA1-1A499E829BE6Q36022241-1324C70F-7A7E-4136-931E-7FE105A0E03CQ36035951-DB033A75-2E30-4584-AF60-A4D7C4A27455Q36037967-0A92947D-3DF9-4C5D-894A-BFBCFC8906A8Q36042596-A2DA7038-DA19-41CC-B87B-8050D85B5D29Q36053940-08752E46-A033-401E-8196-F7E74E851FB5Q36057585-88275DDD-4B2C-4B5E-983F-F9F312CFD86AQ36087138-10BEF9F8-9015-4201-A9B4-35EA62526F11
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The role of EZH2 in tumour progression
@ast
The role of EZH2 in tumour progression
@en
The role of EZH2 in tumour progression
@nl
type
label
The role of EZH2 in tumour progression
@ast
The role of EZH2 in tumour progression
@en
The role of EZH2 in tumour progression
@nl
prefLabel
The role of EZH2 in tumour progression
@ast
The role of EZH2 in tumour progression
@en
The role of EZH2 in tumour progression
@nl
P2860
P921
P3181
P356
P1476
The role of EZH2 in tumour progression
@en
P2093
P2860
P2888
P3181
P356
10.1038/BJC.2011.551
P407
P577
2012-01-17T00:00:00Z
P5875
P6179
1034969482